Target intelligence / Profile preview

Collagen-binding MSCRAMM Acm (Acm)

Target
Acm
Molecular classification
MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) [1], Bacterial adhesin [13], Cell wall-anchored protein [14], LPXTG-surface protein [19]
01

Overview

Enterococcus faecium Acm adhesin (Acm) is a cell wall-anchored protein belonging to the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) family [1, 14]. It is primarily expressed by clinical isolates of E. faecium, particularly those associated with the high-risk hospital-adapted clonal complex 17 (CC17), and is often absent or non-functional in commensal strains [2, 4]. Acm functions as a collagen-binding adhesin, specifically targeting collagen types I and IV, which are abundant in host tissues such as heart valves [3, 10]. This binding is a critical virulence factor in the development of infective endocarditis, as it facilitates the initial attachment and subsequent formation of bacterial vegetations [1, 23]. Because of its central role in pathogenesis and its prevalence in multidrug-resistant strains, Acm is considered a promising therapeutic target [7, 16]. Experimental studies have demonstrated that antibodies directed against the Acm A-domain can effectively block bacterial adherence to collagen, suggesting potential for the development of passive immunotherapies or vaccines to prevent or treat enterococcal infections [4, 17].

Other names
Adhesin of collagen from Enterococcus faecium [1]Fms8 [14]Collagen-binding protein Acm [13]Acm adhesin [1]
02

Mechanism of action

Inhibition of bacterial adherence to host collagen [4, 23]

03

Biological functions

Adhesion [3]Pathogenesis [1]Biofilm formation [11]Colonization [10]
04

Disease associations

Infection [12]Infective endocarditis [1]Urinary tract infection [12]Bacteremia [12]
05

Safety considerations

Therapeutic challenges include the potential for bacteria to utilize alternative adhesins (e.g., Scm, EcbA) to bypass inhibition [19]Potential for cross-reactivity with host proteins [2]
06

Interacting drugs

Anti-Acm antibodies (experimental) [4, 17]
07

Biomarkers

Anti-Acm antibodies [2, 4]

Beyond the preview

Go deeper on Collagen-binding MSCRAMM Acm (Acm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen-binding MSCRAMM Acm (Acm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call